Skip to content

China Medtech Radar

Menu
  • Home
  • Cardiology/Cardiovascular
  • Neurology/Neurovascular
  • Ophthalmology
  • Orthopedics
  • Robotics
  • News & Updates
  • Resources
  • Clinical
  • About
  • Login

Ophthalmology

Notable Devices and Medical Solutions in Ophthalmology Approved by NMPA through Fast Track Channel

JAN 07, 2025

LoongCrystal®PR Type Intraocular Lens Receives the First Approval through NMPA’s Innovative Device Approval Channel in 2025

Trending

The China MedTech Edge: March 2026 Intelligence Briefing

More to Read

The New Competitive Edge: Clinical-Driven Innovation and the Rise of the Surgeon-Technologist in China’s Medtech Landscape

More to Read

China's $14M Bone 02 Glue: The 3-Minute Miracle Cure or Just an Adhesive Fantasy?

More to Read

High-Precision Technology and Global Strategy Driving China’s Next Wave of MedTech IPOs in 2025

More to Read

Beyond Price Cuts: VBP as a Driver for Innovation and Global Reach in Chinese Medtech

More to Read

Operated by IMPELINNO GmbH, China Medtech Radar is your news aggregator for Medtech innovation in China. Knowledge, Insights & Opportunities, that is what we are all about.

[email protected]
Weyermannsstrasse 36
Bern, 3008
Switzerland

Disclaimer

The information provided on this platform is aimed at providing knowledge and updates as of the date indicated. We make no representations or warranties regarding the accuracy, completeness, or reliability of the content obtained from publicly available information as indicated. By using this information, you acknowledge its potential limitations and assume all risks associated with its use. For more information, please see our full Disclaimer and Terms of Use.

← Back

Thank you for your response. ✨


© 2026 China Medtech Radar | WordPress Theme by Superb WordPress Themes
Back to Top ↑